vTv Therapeutics Inc.
VTVT
$16.00
-$0.54-3.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 17.00K | -- | -- | 1.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 17.00K | -- | -- | 1.00M |
| Cost of Revenue | 227.00K | -7.08M | 3.22M | 217.00K | 66.00K |
| Gross Profit | -227.00K | 7.11M | -3.22M | -217.00K | 934.00K |
| SG&A Expenses | 3.67M | 2.68M | 3.28M | 3.72M | 3.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.50M | 4.91M | 6.51M | 7.16M | 6.63M |
| Operating Income | -6.50M | -4.89M | -6.51M | -7.16M | -5.63M |
| Income Before Tax | -6.22M | -4.44M | -5.84M | -6.41M | -5.92M |
| Income Tax Expenses | -- | 0.00 | -- | -- | 100.00K |
| Earnings from Continuing Operations | -6.22M | -4.44M | -5.84M | -6.41M | -6.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.13M | 803.00K | 1.06M | 1.23M | 1.15M |
| Net Income | -5.09M | -3.63M | -4.78M | -5.18M | -4.87M |
| EBIT | -6.50M | -4.89M | -6.51M | -7.16M | -5.63M |
| EBITDA | -6.49M | -4.87M | -6.48M | -7.13M | -5.61M |
| EPS Basic | -0.77 | -0.55 | -0.88 | -0.81 | -0.76 |
| Normalized Basic EPS | -0.42 | -0.30 | -0.48 | -0.43 | -0.40 |
| EPS Diluted | -0.77 | -0.55 | -0.88 | -0.81 | -0.76 |
| Normalized Diluted EPS | -0.42 | -0.30 | -0.48 | -0.43 | -0.40 |
| Average Basic Shares Outstanding | 6.58M | 6.58M | 5.46M | 6.40M | 6.40M |
| Average Diluted Shares Outstanding | 6.58M | 6.58M | 5.46M | 6.40M | 6.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |